» Articles » PMID: 28251231

Serologic Evidence of Toxoplasma Gondii Infection Among Cancer Patients. A Prospective Study from Qassim Region, Saudi Arabia

Overview
Journal Saudi Med J
Specialty General Medicine
Date 2017 Mar 3
PMID 28251231
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the frequency of antibody seropositivity of Toxoplasma gondii  infection in a cancer patient population. We also explored on association of Toxoplasma gondii seropositivity with selected variables. Methods: This is a prospective cross-sectional study conducted at  Prince Faisal bin Bandar cancer center, Qassim, Saudi Arabia, from November 2014 to  March 2015. One hundred thirty seven patients were involved in the study. Demographic data was collected using structured questionnaire, and clinical information was retrieved from the patient's medical reports. Enzyme-linked immunosorbent assay technique was used for antibody assay. Results:   The frequency of seropositivity for Toxoplasma gondii infection was 30.6%. The patient's age range from 1.5-84 years with a geometric mean of 42.7 years. The seropositivity was significantly higher (p<0.05) among the 40-80 years age group (71.4%) as compared  to  0-39 years one (28.6%).   Conclusion: The prevalence of Toxoplasma gondii increases with increasing age among cancer patients in this region of central Saudi Arabia. More research is advisable for better understanding of ageing in pathogenesis of toxoplasmosis among patients with malignancies.

Citing Articles

Serological and molecular detection of Toxoplasma Gondii among cancer patients in Sohag, Upper Egypt: a case-control study.

Fadel E, Tolba M, Ahmed A, El-Hady H Sci Rep. 2025; 15(1):5236.

PMID: 39939648 PMC: 11822034. DOI: 10.1038/s41598-025-88680-3.


The effect of infection with in inducing interferon-gamma in breast cancer patients.

Azab Hameed F, Khalaf A Arch Razi Inst. 2024; 79(1):138-143.

PMID: 39192947 PMC: 11345480. DOI: 10.32592/ARI.2024.79.1.138.


Seroprevalence of Anti- Antibodies among Patients with Cancer at Hiwa Cancer Hospital in Sulaimani City, Kurdistan Region, Iraq.

Mohammed L, Amin A, Mohammed R, Mohammed S, Ahmed L, Ahmed V Iran J Parasitol. 2024; 18(4):526-534.

PMID: 38169672 PMC: 10758079. DOI: 10.18502/ijpa.v18i4.14261.


Seroprevalence of infection in women with a gynecological tumor living in eastern China.

Wang Z, Qu T, Qi H, Zhao S, Shi H, Bai W PeerJ. 2022; 10:e14569.

PMID: 36540800 PMC: 9760017. DOI: 10.7717/peerj.14569.


Toxoplasmosis in immunocompetent Saudi women: Correlation with vitamin D.

Rasheed Z, Shariq A, AlQefari G, Alwahbi G, Aljuaythin A, Alsuhibani F Womens Health (Lond). 2021; 17:17455065211043844.

PMID: 34541980 PMC: 8451252. DOI: 10.1177/17455065211043844.


References
1.
Shin D, Cha D, Hua Q, Cha G, Lee Y . Seroprevalence of Toxoplasma gondii infection and characteristics of seropositive patients in general hospitals in Daejeon, Korea. Korean J Parasitol. 2009; 47(2):125-30. PMC: 2688793. DOI: 10.3347/kjp.2009.47.2.125. View

2.
El-Shahawy I, Khalil M, Bahnass M . Seroprevalence of Toxoplasma gondii in women in Najran City, Saudi Arabia. Saudi Med J. 2014; 35(9):1143-6. View

3.
Almogren A . Antenatal screening for Toxoplasma gondii infection at a tertiary care hospital in Riyadh, Saudi Arabia. Ann Saudi Med. 2011; 31(6):569-72. PMC: 3221125. DOI: 10.4103/0256-4947.87090. View

4.
Carey R, KIMBALL A, Armstrong D, Lieberman P . Toxoplasmosis. Clinical experiences in a cancer hospital. Am J Med. 1973; 54(1):30-8. DOI: 10.1016/0002-9343(73)90080-6. View

5.
Ertug S, Okyay P, Turkmen M, Yuksel H . Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health. 2005; 5:66. PMC: 1177966. DOI: 10.1186/1471-2458-5-66. View